A detailed history of Intellectus Partners, LLC transactions in Standard Biotools Inc. stock. As of the latest transaction made, Intellectus Partners, LLC holds 419,702 shares of LAB stock, worth $696,705. This represents 0.21% of its overall portfolio holdings.

Number of Shares
419,702
Previous 419,702 -0.0%
Holding current value
$696,705
Previous $742,000 9.16%
% of portfolio
0.21%
Previous 0.21%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

SELL
$1.65 - $2.92 $6,296 - $11,142
-3,816 Reduced 0.9%
419,702 $742,000
Q1 2024

May 03, 2024

BUY
$1.87 - $2.78 $674,602 - $1 Million
360,750 Added 574.74%
423,518 $1.15 Million
Q1 2023

May 04, 2023

SELL
$1.3 - $2.24 $5,200 - $8,960
-4,000 Reduced 5.99%
62,768 $122,000
Q4 2022

Feb 02, 2023

SELL
$0.93 - $1.52 $15,252 - $24,928
-16,400 Reduced 19.72%
66,768 $78,000
Q3 2022

Nov 14, 2022

SELL
$1.1 - $2.06 $13,860 - $25,956
-12,600 Reduced 13.16%
83,168 $91,000
Q2 2022

Aug 12, 2022

SELL
$1.6 - $3.99 $20,160 - $50,274
-12,600 Reduced 11.63%
95,768 $153,000
Q1 2022

May 16, 2022

SELL
$2.8 - $3.96 $23,520 - $33,264
-8,400 Reduced 7.19%
108,368 $389,000
Q4 2020

Feb 18, 2021

BUY
$5.45 - $8.65 $635,666 - $1.01 Million
116,636 Added 88360.61%
116,768 $701,000
Q4 2020

Feb 12, 2021

SELL
$5.45 - $8.65 $431,253 - $684,465
-79,129 Reduced 99.83%
132 $701,000
Q3 2020

Nov 16, 2020

SELL
$4.34 - $11.43 $212,256 - $559,007
-48,907 Reduced 38.16%
79,261 $589,000
Q1 2020

May 14, 2020

SELL
$1.24 - $4.35 $37,001 - $129,803
-29,840 Reduced 18.89%
128,168 $326,000
Q2 2019

Aug 08, 2019

SELL
$11.49 - $14.17 $34,470 - $42,510
-3,000 Reduced 1.86%
158,008 $1.95 Million
Q1 2019

May 15, 2019

BUY
$8.47 - $14.36 $78,906 - $133,777
9,316 Added 6.14%
161,008 $2.14 Million
Q4 2018

Feb 14, 2019

BUY
$7.18 - $8.83 $114,901 - $141,306
16,003 Added 11.79%
151,692 $1.31 Million
Q2 2017

Aug 15, 2017

BUY
N/A
135,689
135,689 $548,000

Others Institutions Holding LAB

About STANDARD BIOTOOLS INC.


  • Ticker LAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 78,654,800
  • Market Cap $131M
  • Description
  • Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...
More about LAB
Track This Portfolio

Track Intellectus Partners, LLC Portfolio

Follow Intellectus Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intellectus Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intellectus Partners, LLC with notifications on news.